Concentrix (CNXC) Stock Forecast, Price Target & Predictions
CNXC Stock Forecast
Concentrix stock forecast is as follows: an average price target of $77.50 (represents a 87.15% upside from CNXC’s last price of $41.41) and a rating consensus of 'Buy', based on 4 wall street analysts offering a 1-year stock forecast.
CNXC Price Target
The average price target for Concentrix (CNXC) is $77.50 based on 1-year price targets from 4 Wall Street analysts in the past 3 months, with a price target range of $85.00 to $70.00. This represents a potential 87.15% upside from CNXC's last price of $41.41.
CNXC Analyst Ratings
According to 4 Wall Street analysts, Concentrix's rating consensus is 'Buy'. The analyst rating breakdown for CNXC stock is 0 'Strong Buy' (0.00%), 2 'Buy' (50.00%), 2 'Hold' (50.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Concentrix Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 02, 2024 | David Koning | Robert W. Baird | $70.00 | $51.70 | 35.40% | 69.04% |
| Sep 26, 2024 | Vincent Colicchio | Barrington | $70.00 | $55.58 | 25.94% | 69.04% |
| Aug 28, 2024 | Ruplu Bhattacharya | Bank of America Securities | $85.00 | $74.81 | 13.61% | 105.26% |
| Apr 29, 2024 | Divya Goyal | Scotiabank | $85.00 | $56.86 | 49.49% | 105.26% |
| Jul 13, 2022 | Vincent Colicchio | Barrington | $183.00 | $126.90 | 44.21% | 341.92% |
The latest Concentrix stock forecast, released on Oct 02, 2024 by David Koning from Robert W. Baird, set a price target of $70.00, which represents a 35.40% increase from the stock price at the time of the forecast ($51.70), and a 69.04% increase from CNXC last price ($41.41).
Concentrix Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | 3 | 4 |
| Avg Price Target | - | $75.00 | $77.50 |
| Last Closing Price | $41.41 | $41.41 | $41.41 |
| Upside/Downside | -100.00% | 81.12% | 87.15% |
In the current month, the average price target of Concentrix stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Concentrix's last price of $41.41. This month's average price target is down -100.00% compared to last quarter, and down -100.00% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Sep 23, 2024 | Canaccord Genuity | Buy | Buy | Hold |
| Aug 28, 2024 | Citigroup | - | Neutral | Upgrade |
| Aug 28, 2024 | Bank of America Securities | - | Neutral | Upgrade |
| Apr 29, 2024 | Scotiabank | Outperform | Outperform | Hold |
Concentrix's last stock rating was published by Canaccord Genuity on Sep 23, 2024. The company gave CNXC a "Buy" rating, the same as its previous rate.
Concentrix Financial Forecast
Concentrix Revenue Forecast
| Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.63B | $1.61B | - | - | $1.58B | $1.57B | - | - | $1.40B | $1.37B | - | - |
| Avg Forecast | $2.62B | $2.54B | $2.52B | $2.54B | $2.51B | $2.45B | $2.44B | $2.47B | $2.44B | $2.38B | $2.35B | $2.38B | $2.20B | $1.64B | $1.66B | $1.63B | $1.68B | $1.59B | $1.57B | $1.53B | $1.46B | $1.38B | $1.36B | $1.30B | $1.24B |
| High Forecast | $2.63B | $2.55B | $2.53B | $2.55B | $2.53B | $2.46B | $2.46B | $2.48B | $2.46B | $2.38B | $2.35B | $2.38B | $2.22B | $1.65B | $1.67B | $1.64B | $1.69B | $1.60B | $1.58B | $1.54B | $1.47B | $1.39B | $1.36B | $1.30B | $1.24B |
| Low Forecast | $2.61B | $2.53B | $2.51B | $2.53B | $2.50B | $2.43B | $2.43B | $2.46B | $2.43B | $2.38B | $2.35B | $2.38B | $2.19B | $1.63B | $1.65B | $1.62B | $1.68B | $1.58B | $1.57B | $1.53B | $1.46B | $1.38B | $1.35B | $1.29B | $1.24B |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.00% | 0.97% | - | - | 0.99% | 1.00% | - | - | 1.01% | 1.01% | - | - |
Concentrix's average Quarter revenue forecast for Dec 23 based on 2 analysts is $2.20B, with a low forecast of $2.19B, and a high forecast of $2.22B. CNXC's average Quarter revenue forecast represents a 34.91% increase compared to the company's last Quarter revenue of $1.63B (Aug 23).
Concentrix EBITDA Forecast
| Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | $156.10M | $153.18M | - | - | $169.63M | $159.46M | - | - | $224.38M | $202.59M | - | - |
| Avg Forecast | $285.77M | $277.05M | $275.01M | $277.11M | $274.38M | $266.99M | $266.56M | $268.98M | $266.41M | $259.77M | $256.14M | $262.99M | $240.32M | $179.03M | $180.73M | $239.08M | $224.16M | $173.48M | $171.59M | $217.35M | $159.44M | $150.79M | $148.26M | $184.48M | $192.39M |
| High Forecast | $287.38M | $278.61M | $276.55M | $278.66M | $275.92M | $268.49M | $268.05M | $270.13M | $267.91M | $259.84M | $256.14M | $315.59M | $241.67M | $180.04M | $181.75M | $286.90M | $268.99M | $174.13M | $172.24M | $260.82M | $160.04M | $151.36M | $148.81M | $221.38M | $230.87M |
| Low Forecast | $284.30M | $275.63M | $273.59M | $275.68M | $272.96M | $265.61M | $265.19M | $268.33M | $265.04M | $259.70M | $256.14M | $210.39M | $239.09M | $178.11M | $179.80M | $191.27M | $179.32M | $172.88M | $171.00M | $173.88M | $158.89M | $150.28M | $147.75M | $147.58M | $153.91M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.87% | 0.85% | - | - | 0.98% | 0.93% | - | - | 1.49% | 1.37% | - | - |
2 analysts predict CNXC's average Quarter EBITDA for Dec 23 to be $240.32M, with a high of $241.67M and a low of $239.09M. This is 53.96% upper than Concentrix's previous annual EBITDA (Aug 23) of $156.10M.
Concentrix Net Income Forecast
| Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | $77.64M | $78.85M | - | - | $106.69M | $113.14M | - | - | $109.75M | $82.90M | - | - |
| Avg Forecast | $241.76M | $229.50M | $213.21M | $215.38M | $221.01M | $213.24M | $196.19M | $194.68M | $198.91M | $187.98M | $170.02M | $126.54M | $198.90M | $184.22M | $178.06M | $115.03M | $122.41M | $192.30M | $182.59M | $104.58M | $175.47M | $145.25M | $146.76M | $81.23M | $63.35M |
| High Forecast | $243.53M | $231.17M | $214.77M | $216.96M | $222.62M | $214.80M | $197.62M | $197.27M | $200.90M | $188.81M | $170.02M | $151.84M | $199.54M | $185.57M | $179.36M | $138.04M | $146.90M | $193.24M | $183.48M | $125.49M | $176.32M | $145.96M | $147.48M | $97.48M | $76.02M |
| Low Forecast | $240.14M | $227.96M | $211.78M | $213.94M | $219.53M | $211.81M | $194.88M | $192.74M | $196.26M | $187.14M | $170.01M | $101.23M | $198.25M | $182.99M | $176.87M | $92.03M | $97.93M | $191.45M | $181.78M | $83.66M | $174.69M | $144.60M | $146.11M | $64.99M | $50.68M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.42% | 0.44% | - | - | 0.55% | 0.62% | - | - | 0.76% | 0.56% | - | - |
Concentrix's average Quarter net income forecast for Dec 23 is $198.90M, with a range of $198.25M to $199.54M. CNXC's average Quarter net income forecast represents a 156.19% increase compared to the company's last Quarter net income of $77.64M (Aug 23).
Concentrix SG&A Forecast
| Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | $431.43M | $417.66M | - | - | $409.30M | $402.00M | - | - | $329.96M | $354.50M | - | - |
| Avg Forecast | $718.05M | $696.14M | $691.01M | $696.27M | $689.42M | $670.85M | $669.77M | $675.86M | $669.41M | $652.71M | $643.60M | $447.97M | $603.86M | $449.85M | $454.12M | $407.24M | $356.53M | $435.89M | $431.16M | $370.22M | $400.63M | $378.89M | $372.52M | $321.20M | $331.76M |
| High Forecast | $722.08M | $700.05M | $694.89M | $700.18M | $693.29M | $674.62M | $673.53M | $678.74M | $673.17M | $652.89M | $643.60M | $537.56M | $607.25M | $452.37M | $456.67M | $488.69M | $427.83M | $437.53M | $432.77M | $444.27M | $402.13M | $380.31M | $373.91M | $385.44M | $398.11M |
| Low Forecast | $714.35M | $692.55M | $687.45M | $692.69M | $685.87M | $667.40M | $666.32M | $674.21M | $665.96M | $652.53M | $643.60M | $358.37M | $600.75M | $447.53M | $451.78M | $325.79M | $285.22M | $434.40M | $429.68M | $296.18M | $399.25M | $377.59M | $371.24M | $256.96M | $265.41M |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.96% | 0.92% | - | - | 0.94% | 0.93% | - | - | 0.87% | 0.95% | - | - |
Concentrix's average Quarter SG&A projection for Dec 23 is $603.86M, based on 2 Wall Street analysts, with a range of $600.75M to $607.25M. The forecast indicates a 39.97% rise compared to CNXC last annual SG&A of $431.43M (Aug 23).
Concentrix EPS Forecast
| Dec 26 | Aug 26 | May 26 | Mar 26 | Dec 25 | Aug 25 | May 25 | Mar 25 | Dec 24 | Aug 24 | May 24 | Mar 24 | Dec 23 | Aug 23 | May 23 | Mar 23 | Dec 22 | Aug 22 | May 22 | Mar 22 | Dec 21 | Aug 21 | May 21 | Mar 21 | Dec 20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 3 | 3 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.50 | $1.51 | - | - | $2.05 | $2.16 | - | - | $2.10 | $1.59 | - | - |
| Avg Forecast | $3.73 | $3.54 | $3.29 | $3.33 | $3.41 | $3.29 | $3.03 | $3.01 | $3.07 | $2.90 | $2.63 | $2.58 | $3.07 | $2.85 | $2.75 | $2.60 | $3.33 | $2.97 | $2.82 | $2.70 | $2.71 | $2.24 | $2.27 | $2.11 | $2.03 |
| High Forecast | $3.76 | $3.57 | $3.32 | $3.35 | $3.44 | $3.32 | $3.05 | $3.05 | $3.10 | $2.92 | $2.63 | $2.58 | $3.08 | $2.87 | $2.77 | $2.61 | $3.35 | $2.98 | $2.83 | $2.71 | $2.72 | $2.25 | $2.28 | $2.12 | $2.04 |
| Low Forecast | $3.71 | $3.52 | $3.27 | $3.30 | $3.39 | $3.27 | $3.01 | $2.98 | $3.03 | $2.89 | $2.63 | $2.58 | $3.06 | $2.83 | $2.73 | $2.58 | $3.31 | $2.96 | $2.81 | $2.69 | $2.70 | $2.23 | $2.26 | $2.10 | $2.02 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.53% | 0.55% | - | - | 0.69% | 0.77% | - | - | 0.94% | 0.70% | - | - |
According to 2 Wall Street analysts, Concentrix's projected average Quarter EPS for Dec 23 is $3.07, with a low estimate of $3.06 and a high estimate of $3.08. This represents a 104.79% increase compared to CNXC previous annual EPS of $1.50 (Aug 23).
Concentrix Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| CLVT | Clarivate | $6.45 | $14.33 | 122.17% | Buy |
| CNXC | Concentrix | $41.41 | $77.50 | 87.15% | Buy |
| WNS | WNS | $47.72 | $72.86 | 52.68% | Buy |
| CDW | CDW | $191.10 | $232.80 | 21.82% | Buy |
| ACN | Accenture | $343.90 | $375.07 | 9.06% | Buy |
| G | Genpact | $38.78 | $42.25 | 8.95% | Hold |
| ASGN | ASGN | $91.43 | $99.00 | 8.28% | Hold |
| GLOB | Globant | $212.01 | $227.00 | 7.07% | Buy |
| PRFT | Perficient | $75.96 | $81.00 | 6.64% | Hold |
| CTSH | Cognizant Technology Solutions | $74.90 | $75.88 | 1.31% | Hold |
| PSN | Parsons | $109.61 | $103.83 | -5.27% | Buy |
| CACI | CACI | $553.27 | $491.11 | -11.24% | Buy |
| SAIC | Science Applications | $146.14 | $124.30 | -14.94% | Buy |
| LDOS | Leidos | $186.32 | $156.64 | -15.93% | Buy |
| EXLS | ExlService | $42.12 | $32.64 | -22.51% | Buy |
CNXC Forecast FAQ
Is Concentrix a good buy?
Yes, according to 4 Wall Street analysts, Concentrix (CNXC) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 50.00% of CNXC's total ratings.
What is CNXC's price target?
Concentrix (CNXC) average price target is $77.5 with a range of $70 to $85, implying a 87.15% from its last price of $41.41. The data is based on 4 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will Concentrix stock go up soon?
According to Wall Street analysts' prediction for CNXC stock, the company can go up by 87.15% (from the last price of $41.41 to the average price target of $77.5), up by 105.26% based on the highest stock price target, and up by 69.04% based on the lowest stock price target.
Can Concentrix stock reach $60?
CNXC's average twelve months analyst stock price target of $77.5 supports the claim that Concentrix can reach $60 in the near future.
Did the CNXC's actual financial results beat the analysts' financial forecasts?
In terms of the last quarterly report (Aug 2023), Concentrix's revenue was $1.63B, missing the average analysts' forecast of $1.64B by -0.50%. The company's EBITDA was $156.1M, missing the average prediction of $179.03M by -12.81%. Concentrix's net income was $77.64M, missing the average estimation of $184.22M by -57.86%. The company's SG&A was $431.42M, missing the average forecast of $449.85M by -4.10%. Lastly, the company's EPS was $1.5, missing the average prediction of $2.85 by -47.28%